CARLSMED, INC. CARL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-23
CARLSMED, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 75.3% | 73.8% |
| Operating margin | -60.5% | -88.8% |
| Net margin | -58.7% | -89.3% |
| FCF margin | -58.6% | -94.4% |
| Return on assets | -22.8% | -46.8% |
| Return on equity | -30.0% | 34.3% |
| Debt / equity | 0.16× | -0.22× |
| Current ratio | 8.87 | 5.60 |
| Revenue growth | 85.9% | — |
Source: SEC EDGAR filings · CIK 0001794546 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.